In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens.
Understanding estrogen's regulation of phase II detoxification enzymes is important in explaining how estrogen exposure increases the risk of developing certain cancers. Phase II enzymes such as glutathione-S-transferases (GST) and quinone reductase protect against developing chemically induced cancers by metabolizing reactive oxygen species. Phase II enzyme expression is regulated by a cis-acting DNA sequence, the antioxidant response element (ARE). It has previously been reported that several antiestrogens, but not 17beta-estradiol, could regulate ARE-mediated gene transcription. Our goal was to determine whether additional estrogenic compounds could regulate ARE-mediated gene expression both in vitro and in vivo. We discovered that physiological concentrations (10 nm) of 17beta-estradiol repressed GST Ya ARE-dependent gene expression in vitro. Treatment with other endogenous and anti-, xeno-, and phytoestrogens showed that estrogen receptor/ARE signaling is ligand, receptor subtype, and cell type specific. Additionally, GST and quinone reductase activities were significantly lowered in a dose-dependent manner after 17beta-estradiol exposure in the uteri of mice. In conclusion, we have shown that 17beta-estradiol, and other estrogens, down-regulate phase II enzyme activities. We propose estrogen-mediated repression of phase II enzyme activities may increase cellular oxidative DNA damage that ultimately can result in the formation of cancer in some estrogen-responsive tissues.
Ansell
P J
PJ
Department of Biochemistry, MU Center for Phytonutrient and Phytochemical Studies, University of Missouri, Columbia, Missouri 65211, USA.
Espinosa-Nicholas
C
C
Curran
E M
EM
Judy
B M
BM
Philips
B J
BJ
Hannink
M
M
Lubahn
D B
DB
D000818:Animals; D000975:Antioxidants / Q000502:physiology*; D001483:Base Sequence; D001943:Breast Neoplasms; D019556:COS Cells; D045744:Cell Line, Tumor; D004789:Enzyme Activation / Q000187:drug effects; D004967:Estrogens / Q000494:pharmacology / Q000502:physiology*; D005260:Female; D015870:Gene Expression / Q000502:physiology; D005982:Glutathione Transferase / Q000235:genetics*; D006801:Humans; D066298:In Vitro Techniques; D007529:Isoflavones / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000235:genetics*; D048789:Phytoestrogens; D028321:Plant Preparations / Q000494:pharmacology; D011960:Receptors, Estrogen / Q000235:genetics; D020218:Response Elements / Q000235:genetics; D014162:Transfection
D000975:Antioxidants; D004967:Estrogens; D007529:Isoflavones; D048789:Phytoestrogens; D028321:Plant Preparations; D011960:Receptors, Estrogen; D016660:NAD(P)H Dehydrogenase (Quinone); D005982:Glutathione Transferase